Blog Category:

The Force Awakens—Unlocking the Potential of IL-23–targeted Therapies in the Treatment of IBD

The therapeutic armamentarium for inflammatory bowel disease (IBD) is expanding with the advent of anti–IL-23 therapies. The unique clinical profiles of new and emerging agents make it necessary that treatment decisions are guided by evolving knowledge of the science surrounding …

Strategies for Equitable, Affirming, and Accessible Clinical Practices in Neurodiverse Care

Individuals who are neurodivergent face disparities in quality of care, communication access, and employment, particularly nonverbal individuals and those with intellectual disabilities. Implicit bias and limited access to key services exacerbate these challenges. Executive functioning, sensory differences, and anxiety can …

An Introduction to Neurodiversity: What Clinicians Need to Know

Neurodiversity emphasizes diverse ways of thinking, learning, and behaving, and posits that people interact with their surroundings in many ways, with differences being strengths versus deficits. Health care professionals (HCPs) can improve outcomes for individuals who are neurodivergent by focusing …

Health Inequities in Adult Obesity Care

Obesity care is an ongoing concern for clinicians and caregivers, particularly those who care for individuals in communities with limited resources and higher rates of overlapping comorbidities. Compounding these concerns are the forms of bias that can affect care for …

It’s Not Just Obesity: Addressing Cardiometabolic Comorbidities in Underserved Communities

It is critical that health care professionals (HCPs) address disparities associated with obesity, which is strongly linked to cardiometabolic comorbidities such as cardiovascular disease (CVD), diabetes, hypertension, and dyslipidemia – conditions that affect individuals across various populations. While increasingly effective …

Reimagining Management of Generalized Myasthenia Gravis: A Focus on FcRn Antagonists

Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …

Expanding Horizons in Obesity Care: Innovative Treatments, Guidelines, and Personalized, Equitable Approaches

The guidelines for obesity care have been changing, including approaches to diagnosis, innovative treatments and recommendations, and management strategies; however, obesity care for those in underserved communities has not kept pace. Clinicians in these communities need education: not only about …

Modern Approaches to Obesity Care for All Populations: Addressing Root Causes

To provide equitable obesity care, caregivers must challenge the common misperception of obesity as the result of character flaws; instead, they must recognize obesity as a chronic disease with genetic, socioeconomic, and cultural components. Implicit bias, the oftentimes subconscious misperceptions …

Initiating Basal Insulin: Moving from Hesitancy to Action

More than 32 million adults in the United States currently have diabetes, 90% of whom have type 2 diabetes (T2D) which can lead to both microvascular and macrovascular complications, and greatly compromise health-related quality of life (HRQoL) and confer significant …